Phylogenetic and structural analysis of the phospholipase A2 gene family in vertebrates

Huang,Qi; Wu,Yuan; Qin,Chao; He,Wenwu; Wei,Xing

doi:10.3892/ijmm.2014.2047

Phylogenetic and structural analysis of the phospholipase A2 gene family in vertebrates

Authors:
- Qi Huang
- Yuan Wu
- Chao Qin
- Wenwu He
- Xing Wei
View Affiliations

Affiliations: Department of Neurology, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China, Department of Cardiothoracic Surgery, Nanchong Central Hospital, The Second Clinical College of North Sichuan Medical College, Nanchong, Sichuan, P.R. China
Published online on: December 23, 2014 https://doi.org/10.3892/ijmm.2014.2047
Pages: 587-596
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The phospholipase A (PLA)2 family is the most complex gene family of phospholipases and plays a crucial role in a number of physiological activities. However, the phylogenetic background of the PLA2 gene family and the amino acid residues of the PLA2G7 gene following positive selection gene remain undetermined. In this study, we downloaded 49 genomic data sets of PLA from different species, including the human, house mouse, Norway rat, pig, dog, chicken, cattle, African clawed frog, Sumatran orangutan and the zebrafish species. Phylogenetic relationships were determined using the neighbor-joining (NJ), minimum evolution (ME) and maximum parsimony (MP) methods, as well as the Bayesian information criterion. The results were then presented as phylogenetic trees. Positive selection sites were detected using site, branch and branch‑site models. These methods led us to the following assumptions: i) closer lineages were observed between PLA2G16 and PLA2G6, PLA2G7 and PLA2G4, PLA2G3 and PLA2G12, as well as among PLA2G10, PLA2G5 and PLA2G15; ii) PLA2G5 appeared to be the origin of the PLA2 family, and PLA2G7 was one of the most evolutionarily distant PLA2 proteins; iii) 16 positive-selection sites were detected and were marked in the PLA2G7 protein sequence as 327D, 257Q, 276G, 34s, 66G, 67C, 319S, 28N, 50S, 54T, 58R, 75T, 88Q, 92R, 179H and 191K.

View Figures

View References

1	Heinrikson RL, Krueger ET and Keim PS: Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem. 252:4913–4921. 1977.PubMed/NCBI
2	de Beer FC and Webb NR: Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundant. Arterioscler Thromb Vasc Biol. 26:1421–1422. 2006. View Article : Google Scholar : PubMed/NCBI
3	Starkl P, Marichal T and Galli SJ: PLA2G3 promotes mast cell maturation and function. Nat Immunol. 14:527–529. 2013. View Article : Google Scholar : PubMed/NCBI
4	Mackenzie LS, Lymn JS and Hughes AD: Linking phospholipase C isoforms with differentiation function in human vascular smooth muscle cells. Biochim Biophys Acta. 1833.3006–3012. 2013.
5	Clark JD, Schievella AR, Nalefski EA and Lin LL: Cytosolic phospholipase A2. J Lipid Mediat Cell Signal. 12:83–117. 1995. View Article : Google Scholar : PubMed/NCBI
6	Johansson P and Thesleff S: A comparison of the effects of phos-pholipase C and tetrodotoxin on spike generation in muscle. Eur J Pharmacol. 4:347–348. 1968. View Article : Google Scholar : PubMed/NCBI
7	Jackson TN, Sunagar K, Undheim EA, et al: Venom down under: dynamic evolution of Australian elapid snake toxins. Toxins (Basel). 5:2621–2655. 2013. View Article : Google Scholar
8	Margres MJ, Aronow K, Loyacano J and Rokyta DR: The venom-gland transcriptome of the eastern coral snake (Micrurus fulvius) reveals high venom complexity in the intragenomic evolution of venoms. BMC Genomics. 14(531): 2013
9	Dennis EA: Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 269:13057–13060. 1994.PubMed/NCBI
10	Smith AD and Winkler H: Lysosomal phospholipases A1 and A2 of bovine adrenal medulla. Biochem J. 108:867–874. 1968.PubMed/NCBI
11	Pan YH, Yu BZ, Berg OG, Jain MK and Bahnson BJ: Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive. Biochemistry. 41:14790–14800. 2002. View Article : Google Scholar : PubMed/NCBI
12	Ohtsuki T, Watanabe H, Toru M and Arinami T: Lack of evidence for associations between plasma platelet-activating factor acetyl-hydrolase deficiency and schizophrenia. Psychiatry Res. 109:93–96. 2002. View Article : Google Scholar : PubMed/NCBI
13	Hixon MS, Ball A and Gelb MH: Calcium-dependent and -independent interfacial binding and catalysis of cytosolic group IV phospholipase A2. Biochemistry. 37:8516–8526. 1998. View Article : Google Scholar : PubMed/NCBI
14	Retraction: CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke. J Biol Chem. 288(7549): 2013
15	Fitzpatrick AL, Irizarry MC, Cushman M, Jenny NS, Chi GC and Koro C: Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study. Atherosclerosis. 235:384–391. 2014. View Article : Google Scholar : PubMed/NCBI
16	Gui YX, Xu ZP, Wen-Lv Q, Liu HM, Zhao JJ and Hu XY: Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease. Parkinsonism Relat Disord. 19:21–26. 2013. View Article : Google Scholar
17	Farooqui AA, Ong WY and Horrocks LA: Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev. 58:591–620. 2006. View Article : Google Scholar : PubMed/NCBI
18	Holmes MV, Simon T, Exeter HJ, et al: Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 62:1966–1976. 2013. View Article : Google Scholar : PubMed/NCBI
19	Ohno M, Menez R, Ogawa T, et al: Molecular evolution of snake toxins: is the functional diversity of snake toxins associated with a mechanism of accelerated evolution? Prog Nucleic Acid Res Mol Biol. 59:307–364. 1998. View Article : Google Scholar : PubMed/NCBI
20	Edgar RC: MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 5(113): 2004
21	Suyama M, Torrents D and Bork P: PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res. 34:W609–W612. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kumar S, Tamura K and Nei M: MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 5:150–163. 2004. View Article : Google Scholar : PubMed/NCBI
23	Posada D: Using MODELTEST and PAUP^* to select a model of nucleotide substitution. Curr Protoc Bioinformatics. Chapter 6: Unit 6.5. 2003.
24	Guindon S and Gascuel O: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 52:696–704. 2003. View Article : Google Scholar : PubMed/NCBI
25	Posada D and Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics. 14:817–818. 1998. View Article : Google Scholar
26	Ronquist F and Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 19:1572–1574. 2003. View Article : Google Scholar : PubMed/NCBI
27	Huelsenbeck JP and Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics. 17:754–755. 2001. View Article : Google Scholar : PubMed/NCBI
28	Yang Z: PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol. 24:1586–1591. 2007. View Article : Google Scholar : PubMed/NCBI
29	Yang Z, Wong WS and Nielsen R: Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol. 22:1107–1118. 2005. View Article : Google Scholar : PubMed/NCBI
30	Nielsen R and Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics. 148:929–936. 1998.PubMed/NCBI
31	Rost B, Yachdav G and Liu J: The PredictProtein server. Nucleic Acids Res. 32:W321–W326. 2004. View Article : Google Scholar : PubMed/NCBI
32	Roy A, Yang J and Zhang Y: COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res. 40:W471–W477. 2012. View Article : Google Scholar : PubMed/NCBI
33	Roy A, Kucukural A and Zhang Y: I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 5:725–738. 2010. View Article : Google Scholar : PubMed/NCBI
34	Zhang Y: I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 9(40): 2008
35	Saitou N and Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 4:406–425. 1987.PubMed/NCBI
36	Thompson EA: The method of minimum evolution. Ann Hum Genet. 36:333–340. 1973. View Article : Google Scholar : PubMed/NCBI
37	Goodman M, Moore GW, Barnabas J and Matsuda G: The phylogeny of human globin genes investigated by the maximum parsimony method. J Mol Evol. 3:1–48. 1974. View Article : Google Scholar : PubMed/NCBI
38	Xin H, Chen ZY, Lv XB, Liu S, Lian ZX and Cai SL: Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction. Eur Rev Med Pharmacol Sci. 17:999–1004. 2013.PubMed/NCBI
39	Sullivan AH: A measurement of the local energy deposition by antiprotons coming to rest in tissue-like material. Phys Med Biol. 30:1297–1303. 1985. View Article : Google Scholar : PubMed/NCBI
40	Duivenvoorden R, Mani V, Woodward M, et al: Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC Cardiovasc Imaging. 6:1087–1094. 2013. View Article : Google Scholar : PubMed/NCBI
41	Mangili A, Ahmad R, Wolfert RL, et al: Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients. Clin Infect Dis. 58:893–900. 2014. View Article : Google Scholar
42	Hariprasad G, Srinivasan A and Singh R: Structural and phylogenetic basis for the classification of group III phospholipase A2. J Mol Model. 19:3779–3791. 2013. View Article : Google Scholar : PubMed/NCBI
43	Magrioti V and Kokotos G: Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. Expert Opin Ther Pat. 20:1–18. 2010. View Article : Google Scholar
44	Gibbs HL and Rossiter W: Rapid evolution by positive selection and gene gain and loss: PLA₂ venom genes in closely related Sistrurus rattlesnakes with divergent diets. J Mol Evol. 66:151–166. 2008. View Article : Google Scholar : PubMed/NCBI
45	Woodgett JR, Gould KL and Hunter T: Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem. 161:177–184. 1986. View Article : Google Scholar : PubMed/NCBI
46	Pinna LA: Casein kinase 2: an ‘eminence grise’ in cellular regulation? Biochim Biophys Acta. 1054:267–284. 1990. View Article : Google Scholar : PubMed/NCBI
47	Chapus C, Rovery M, Sarda L and Verger R: Minireview on pancreatic lipase and colipase. Biochimie. 70:1223–1234. 1988. View Article : Google Scholar : PubMed/NCBI
48	Caslake MJ and Packard CJ: Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Curr Opin Lipidol. 14:347–352. 2003. View Article : Google Scholar : PubMed/NCBI
49	Feng LM, Feng GF and Chen Y: Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese Han adult serum. Lipids Health Dis. 13(6): 2014
50	Harvey EJ, Li N and Ramji DP: Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis. Arterioscler Thromb Vasc Biol. 27:806–812. 2007. View Article : Google Scholar : PubMed/NCBI
51	Tai W, Garcia M, Mlynash M, Kemp S, Albers GW and Olivot JM: Lipoprotein phospholipase A2 mass and activity are not associated with the diagnosis of acute brain ischemia. Cerebrovasc Dis. 38:324–327. 2014. View Article : Google Scholar : PubMed/NCBI
52	Nozadze DN, Sergienko IV, Balakhonova TV, Semenova AE, Vlasik TN and Kukharchuk VV: Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk. Kardiologiia. 54:57–63. 2014.(In Russian).